<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03326531</url>
  </required_header>
  <id_info>
    <org_study_id>NL56402.068.16</org_study_id>
    <nct_id>NCT03326531</nct_id>
  </id_info>
  <brief_title>&quot;Gait and Balance in Patients With SCFE&quot;</brief_title>
  <official_title>Slipped Capital Femoral Epiphysis; Changes in Gait, Balance and Muscle Activity Patterns in Patients Treated With Single Screw in Situ Fixation Investigated Using Computer Assisted Rehabilitation ENvironment (CAREN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in&#xD;
      an altered gait. It is thought that the protraction of the pelvis at the affected side, seen&#xD;
      in patients with unilateral stable SCFE, is a compensatory mechanism to reduce out-toeing and&#xD;
      thereby improve foot positioning during gait. This study will evaluate this hypothesis since&#xD;
      only a few studies are conducted evaluating gait in treated SCFE. It is also thought that&#xD;
      this pathology results in an impaired balance. Computer Assisted Rehabilitation Environment&#xD;
      (CAREN) will be used to investigate these two questions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation&#xD;
      results in an altered gait. It is thought that the protraction of the pelvis at the affected&#xD;
      side, seen in patients with unilateral stable SCFE, is a compensatory mechanism to reduce&#xD;
      out-toeing and thereby improve foot positioning to restores the gait patterns towards a&#xD;
      'normal gait pattern. The goal of this study is to investigate this hypothesis since only a&#xD;
      few studies are conducted evaluating gait in treated SCFE. It is also thought that this&#xD;
      pathology results in an impaired balance. Computer Assisted Rehabilitation Environment&#xD;
      (CAREN) will be used.&#xD;
&#xD;
      Objective: The primary objective of this study is to investigate whether protraction of the&#xD;
      pelvis at the affected side is a compensatory mechanism to reduce out-toeing and thereby&#xD;
      improve foot positioning and restores the gait pattern towards a 'normal' gait pattern in&#xD;
      patients with unilateral stable SCFE, treated with single screw in situ fixation. Dynamic&#xD;
      postural balance will be analysed as well since an altered, waddling gait, is observed in&#xD;
      patients with treated SCFE. In addition, activity patterns of lower limb muscles will also be&#xD;
      evaluated using surface electromyography. Kinematic and EMG data of patients will be compared&#xD;
      with data of healthy controls with no gait pathology in order to investigate these&#xD;
      objectives.&#xD;
&#xD;
      Secondary objectives are the evaluation of clinical outcomes and spatiotemporal parameters in&#xD;
      these patients compared to healthy controls.&#xD;
&#xD;
      Study design: a comparative cross-sectional case-control study.&#xD;
&#xD;
      Study population: Children and adolescents with stable SCFE managed with single screw in situ&#xD;
      fixation and an age, gender and BMI matched healthy controls without gait pathology. Patients&#xD;
      were excluded if major complications occurred due to in situ fixation, if they had revision&#xD;
      surgery or had additional pathology leading to gait alterations. In addition, patients are&#xD;
      required to walk without walking aid for at least 30 minutes.&#xD;
&#xD;
      Main study parameters/endpoints: Kinematic data will be studied at pelvis, hip, knee and&#xD;
      ankle level. Margins of stability will be calculated to analyse dynamic postural balance. In&#xD;
      addition, lower extremity muscle activation patterns of SCFE patients will be recorded to&#xD;
      assess muscle activation pattern during gait. Correlations between the severity of initial&#xD;
      slip and the clinical outcome after treatment will be evaluated.&#xD;
&#xD;
      Nature and extent of the burden and risks associated with participation, benefit and group&#xD;
      relatedness: The risk of CAREN based gait analysis is negligible. A safety harness provides&#xD;
      protection against falling. It will avoid subject falling on or off the treadmill while&#xD;
      performing training. The safety harness is secured with a life line to the ceiling. The&#xD;
      burden of the children or adolescents is minimal. Participants will visit the MUMC+ once,&#xD;
      where questionnaires (Hip Injury Osteoarthritis Outcome Score, SF-36 questionnaires, Borg&#xD;
      CR10 Score and NRS score) physical examination and gait analysis will be performed. The whole&#xD;
      session will take 2 hours. Due to the nature of the study, this study can only be done using&#xD;
      this specific patient group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Joint range of motion</measure>
    <time_frame>During an entire gait cycle while walking on the CAREN system during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Range of motion (i.e. maximal angle minus minimal angle in degrees) of the pelvis, hip, knee and ankle of the affected and unaffected side in degrees.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Absolute joint angles</measure>
    <time_frame>During an entire gait cycle while walking on the CAREN system during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Absolute joint angles of the pelvis, hip, knee and ankle of both the affected and unaffected side in degrees.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Margins of Stability</measure>
    <time_frame>During an entire gait cycle while walking on the CAREN system during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Margins of Stability is a measure to describe balance during gait</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle activation patterns</measure>
    <time_frame>During an entire gait cycle while walking on the CAREN system during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Muscle activation patterns of lower limb muscles will be recorded during gait by using EMG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait velocity</measure>
    <time_frame>During an entire gait cycle while walking on the CAREN system during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Gait velocity (in m/sec)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hip Injury and Osteoarthritis Outcome Score</measure>
    <time_frame>One minute before the start of the test on the CAREN system during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Scoring system to assess general outcome after hip surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>One minute before the start of the test on the CAREN system during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Scoring system to assess quality of life after hip surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Borg CR10 scale</measure>
    <time_frame>One minute before the test on the CAREN system and one minute after the last gait cycle walked on the CAREN system during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Scoring system to assess the severity of tiredness during the test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS/VAS score</measure>
    <time_frame>One minute before the test on the CAREN system and one minute after the last gait cycle walked on the CAREN system during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Scoring system to assess pain during the test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological outcome</measure>
    <time_frame>Assessed during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>The Southwick Angle is used to assess the severity of initial slip</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cadence (in steps/min)</measure>
    <time_frame>During the entire gait cycle while walking on the CAREN system, during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Cadance (in steps/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Step width (in cm) and stride length (in cm)</measure>
    <time_frame>During the entire gait cycle while walking on the CAREN system, during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Step width and stride length (in cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of the gait cycle spent in stance (in seconds)</measure>
    <time_frame>During the entire gait cycle while walking on the CAREN system, during the only study visit moment (e.g. 6 months till 10 years after surgery).</time_frame>
    <description>Stance phase (in seconds)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Slipped Capital Femoral Epiphyses</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Not applicable for this study</intervention_name>
    <description>Not applicable for this study</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We expect that no major deviations in gait pattern occur later than 6 months after the&#xD;
        intervention and therefore, a stable gait pattern is presented 6 months postoperatively.&#xD;
        This expectation is made based on clinical experience, in which gait is often affected&#xD;
        during these first 6 months after the intervention due to pain, a long non-weightbearing&#xD;
        period of the leg in the postoperative phase and rehabilitation. After these six months no&#xD;
        further deviations in gait pattern were expected and a stable, compensating gait pattern is&#xD;
        observed and patients will be analysed between 6 months till 10 years postoperatively.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged between 8 and 21 years.&#xD;
&#xD;
          -  Unilateral stable SCFE, with clinical and radiological confirmation and lateral slip&#xD;
             angles ranging from mild (LSA &lt;30째), moderate (LSA 30째-50째) to severe (LSA &gt;50째) based&#xD;
             on the method of Southwick.&#xD;
&#xD;
          -  Treatment of the slip with single screw in situ fixation in the last ten years, with&#xD;
             no evidence of major complications related to the procedure like chondrolysis,&#xD;
             avascular necrosis and infection or slip progression. Follow up at our institution for&#xD;
             at least one year.&#xD;
&#xD;
          -  Ability to walk 30 minutes without aid.&#xD;
&#xD;
          -  Is able to speak, read and write the Dutch language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinical or radiological evidence of a contralateral slip or an endocrinopathy as&#xD;
             underlying cause of SCFE.&#xD;
&#xD;
          -  Revision surgery.&#xD;
&#xD;
          -  Other pathology leading to gait alterations.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Adhiambo M. Witlox, PhD, MD</last_name>
    <phone>+31433875038</phone>
    <email>ma.witlox@mumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jasper Stevens, MD, PhD-candidate</last_name>
    <phone>+31433875038</phone>
    <email>jasper.stevens@mumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maastricht University Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6202AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adhiambo M. Witlox, MD, PhD</last_name>
      <phone>0031433875038</phone>
      <email>ma.witlox@mumc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Jasper Stevens, MD, PhD-candidate</last_name>
      <phone>0031433875038</phone>
      <email>jasper.stevens@mumc.nl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>September 27, 2017</study_first_submitted>
  <study_first_submitted_qc>October 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>January 15, 2018</last_update_submitted>
  <last_update_submitted_qc>January 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Slipped Capital Femoral Epiphyses</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

